Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab

Arthritis Research and Therapy

Volumn 10, Issue 5, 2008, Pages

  Rosengren, Sanna ^a   Wei, Nathan ^b   Kalunian, Kenneth C ^a   Zvaifler, Nathan J ^a   Kavanaugh, Arthur ^a   Boyle, David L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Arthritis and Osteoporosis Center of Maryland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; MESSENGER RNA; RHEUMATOID FACTOR; RITUXIMAB; ANTIRHEUMATIC AGENT; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; JOINT BIOPSY; LEUKOCYTE AGGREGATION; LYMPHOCYTE DEPLETION; LYMPHOCYTIC INFILTRATION; OSTEOARTHRITIS; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SYNOVIUM; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNOVIAL FLUID;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTES; PEPTIDES, CYCLIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHEUMATOID FACTOR; RNA, MESSENGER; SYNOVIAL FLUID;

EID: 52449085305     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2497     Document Type: Article

References (32)

1. Rantapaa-Dahlqvist S de Jong BA Berglin E Hallmans G Wadell G Stenlund H Sundin U van Venrooij WJ Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis Arthritis Rheum 2003, 48:2741-2749. 10.1002/art.11223 14558078
2. Klareskog L Stolt P Lundberg K Kallberg H Bengtsson C Grunewald J Ronnelid J Harris HE Ulfgren AK Rantapaa-Dahlqvist S Eklund A Padyukov L Alfredsson L A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination Arthritis Rheum 2006, 54:38-46. 10.1002/art.21575 16385494
3. Edwards JC Szczepanski L Szechinski J Filipowicz-Sosnowska A Emery P Close DR Stevens RM Shaw T Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis N Engl J Med 2004, 350:2572-2581. 10.1056/NEJMoa032534 15201414
4. Leandro MJ Edwards JC Cambridge G Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion Ann Rheum Dis 2002, 61:883-888. 1753912 12228157 10.1136/ard.61.10.883
5. Cambridge G Leandro MJ Edwards JC Ehrenstein MR Salden M Bodman-Smith M Webster AD Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis Arthritis Rheum 2003, 48:2146-2154. 10.1002/ art.11181 12905467
6. Kavanaugh A Rosengren S Lee SJ Hammaker D Firestein GS Kalunian K Wei N Boyle DL Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: Clinical and synovial biomarker results Ann Rheum Dis 2008, 67:402-408. 10.1136/ard.2007.074229 17644541
7. Vos K Thurlings RM Wijbrandts CA van Schaardenburg D Gerlag DM Tak PP Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis Arthritis Rheum 2007, 56:772-778. 10.1002/ art.22400 17328049
8. Seyler TM Park YW Takemura S Bram RJ Kurtin PJ Goronzy JJ Weyand CM BLyS and APRIL in rheumatoid arthritis J Clin Invest 2005, 115:3083-3092. 1257539 16239971 10.1172/JCI25265
9. Hoffman WL Goldberg MS Smiley JD Immunoglobulin G3 subclass production by rheumatoid synovial tissue cultures J Clin Invest 1982, 69:136-144. 371177 7054235 10.1172/JCI110424
10. Smiley JD Sachs C Ziff M In vitro synthesis of immunoglobulin by rheumatoid synovial membrane J Clin Invest 1968, 47:624-632. 297208 4170150
11. Masson-Bessiere C Sebbag M Durieux JJ Nogueira L Vincent C Girbal-Neuhauser E Durroux R Cantagrel A Serre G In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum Clin Exp Immunol 2000, 119:544-552. 1905590 10691929 10.1046/ j.1365-2249.2000.01171.x
12. Egeland T Lea T Mellbye OJ Pahle JA Ottesen T Natvig JB Quantitation of cells secreting immunoglobulins after elution from rheumatoid synovial tissue Scand J Immunol 1982, 16:413-419. 10.1111/ j.1365-3083.1982.tb00741.x 6758110
13. Wernick RM Lipsky PE Marban-Arcos E Maliakkal JJ Edelbaum D Ziff M IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures Arthritis Rheum 1985, 28:742-752. 10.1002/art.1780280704 4015721
14. Taylor-Upsahl MM Abrahamsen TG Natvig JB Rheumatoid factor plaque-forming cells in rheumatoid synovial tissue Clin Exp Immunol 1977, 28:197-203. 1540764 326444
15. Youinou PY Morrow JW Lettin AW Lydyard PM Roitt IM Specificity of plasma cells in the rheumatoid synovium. I. Immunoglobulin class of antiglobulin-producing cells Scand J Immunol 1984, 20:307-315. 10.1111/ j.1365-3083.1984.tb01007.x 6334356
16. Reparon-Schuijt CC van Esch WJ van Kooten C Schellekens GA de Jong BA van Venrooij WJ Breedveld FC Verweij CL Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis Arthritis Rheum 2001, 44:41-47. 10.1002/ 1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0 11212174
17. Manzo A Paoletti S Carulli M Blades MC Barone F Yanni G Fitzgerald O Bresnihan B Caporali R Montecucco C Uguccioni M Pitzalis C Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis Eur J Immunol 2005, 35:1347-1359. 10.1002/eji.200425830 15832291
18. Rosengren S Firestein GS Boyle DL Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay Clin Diagn Lab Immunol 2003, 10:1002-1010. 262451 14607859 10.1128/ CDLI.10.6.1002-1010.2003
19. Boyle DL Rosengren S Bugbee W Kavanaugh A Firestein GS Quantitative biomarker analysis of synovial gene expression by real-time PCR Arthritis Res Ther 2003, 5:R352-360. 333415 14680510 10.1186/ar1004
20. Borenstein M The case for confidence intervals in controlled clinical trials Control Clin Trials 1994, 15:411-428. 10.1016/ 0197-2456(94)90036-1 8001360
21. Jones VE Jacoby RK Cowley PJ Warren C Immune complexes in early arthritis. II. Immune complex constituents are synthesized in the synovium before rheumatoid factors Clin Exp Immunol 1982, 49:31-40. 1536642 7127902
22. Randen I Thompson KM Natvig JB Forre O Waalen K Human monoclonal rheumatoid factors derived from the polyclonal repertoire of rheumatoid synovial tissue: Production and characterization Clin Exp Immunol 1989, 78:13-18. 1534587 2805416
23. Burger JA Zvaifler NJ Tsukada N Firestein GS Kipps TJ Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism J Clin Invest 2001, 107:305-315. 199194 11160154 10.1172/JCI11092
24. Dechanet J Merville P Durand I Banchereau J Miossec P The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium J Clin Invest 1995, 95:456-463. 295488 7532184 10.1172/JCI117685
25. Radbruch A Muehlinghaus G Luger EO Inamine A Smith KG Dorner T Hiepe F Competence and competition: The challenge of becoming a long-lived plasma cell Nat Rev Immunol 2006, 6:741-750. 10.1038/nri1886 16977339
26. Kim HJ Krenn V Steinhauser G Berek C Plasma cell development in synovial germinal centers in paients with rheumatoid and reactive arthritis J Immunol 1999, 162:3053-3062. 10072558
27. Klimiuk PA Goronzy JJ Björnsson J Beckenbaugh RD Weyand CM Tissue cytokine patterns distinguish variants of rheumatoid synovitis Am J Pathol 1997, 151:1311-1319. 1858087 9358757
28. Randen I Mellbye OJ Forre O Natvig JB The identification of germinal centres and follicular dendritic cell networks in rheumatoid synovial tissue Scand J Immunol 1995, 41:481-486. 10.1111/ j.1365-3083.1995.tb03596.x 7725067
29. Thurlings RM Wijbrandts CA Mebius RE Cantaert T Dinant HJ Pouw-Kraan van der TC Verweij CL Baeten D Tak PP Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype Arthritis Rheum 2008, 58:1582-1589. 10.1002/art.23505 18512774
30. Hamaguchi Y Uchida J Cain DW Venturi GM Poe JC Haas KM Tedder TF The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice J Immunol 2005, 174:4389-4399. 15778404
31. Schroder C Azimzadeh AM Wu G Price JO Atkinson JB Pierson RN Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys Transpl Immunol 2003, 12:19-28. 10.1016/S0966-3274(03)00059-5 14551029
32. Teng YK Levarht EW Hashemi M Bajema IM Toes RE Huizinga TW van Laar JM Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment Arthritis Rheum 2007, 56:3909-3918. 10.1002/ art.22967 18050222